FIRRST试验:意大利多中心随机对照试验——针对早期自闭症谱系障碍迹象婴儿的预防性远程医疗干预
本研究为意大利多中心、单盲、随机、平行组优效性试验,计划招募132名9-14月龄有ASD前驱症状的婴儿,1:1随机分配至FIRRST家长介导远程医疗干预组或家长教育对照组。主要结局为ADOS-2校准严重度评分从基线至干预后(24周)的变化,随访至48周,并评估发育、亲子互动、家长福祉、神经生理及成本效果。
要点
- FIRRST为每周远程健康课程、持续24周的家长介导预防性干预。
- 纳入标准包括SACS-R风险范围评分,排除已知遗传、神经或严重感觉障碍。
- 主要结局为ADOS-2校准严重度评分变化,随访至48周。
核心结论
- 该试验旨在确定FIRRST能否降低有ASD前驱症状婴儿的ADOS-2校准严重度评分。
研究设计与样本
- 多中心、单盲、随机、平行组优效性试验,在意大利大学医院中心招募132名9-14月龄婴儿。
- 按1:1随机分配至FIRRST组或家长教育对照组,按年龄(<12 vs ≥12月)、性别和ASD症状严重度分层。
- 干预为每周远程健康课程,由受训持照健康专业人员实施,持续24周;评估在基线、干预后(24周)和随访(48周)进行。
关键数值与推荐
- 主要结局为ADOS-2校准严重度评分从基线至干预后的变化。
- 次要结局包括Griffiths-III发育水平、MONSI-CC亲子互动、PSI-4家长福祉和高密度脑电图神经生理指标。
- 纳入标准包括SACS-R风险范围评分;排除已知遗传、神经或严重感觉障碍。
- 安全性结局包括不良事件监测和描述性报告;从医疗系统角度进行成本效果分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early prodromal signs of Autism Spectrum Disorder (ASD) can be detected within the first year of life, a period of heightened neuroplasticity. Pre-emptive, parent-mediated interventions delivered during this window may improve developmental outcomes and reduce ASD symptom severity, but evidence from adequately powered randomized trials in Europe remains limited. Early prodromal signs of Autism Spectrum Disorder (ASD) can be detected within the first year of life, a period of heightened neuroplasticity. Pre-emptive, parent-mediated interventions delivered during this window may improve developmental outcomes and reduce ASD symptom severity, but evidence from adequately powered randomized trials in Europe remains limited. OBJECTIVES: The primary objective of this trial is to determine the efficacy of FIRRST (Fostering Infant Responsivity and Reciprocity - Support to Thrive), a parent-mediated pre-emptive telehealth intervention, in reducing ASD symptom severity in infants with ASD prodromes, as measured by change in Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) Calibrated Severity Scores. Secondary objectives are to evaluate effects on infant developmental skills, caregiver-child interaction, parental well-being, neurophysiological markers, and cost-effectiveness. METHODS: This is a multicenter, single-blinded, randomized, parallel-group superiority trial conducted in Italy. A total of 132 infants aged 9-14 months with ASD prodromes will be recruited by clinicians at participating university hospital-based centers and randomly allocated (1:1) to FIRRST or a Parent Education control condition. Key inclusion criteria include risk-range scores on the Social Attention and Communication Surveillance-Revised (SACS-R); exclusion criteria include known genetic, neurological, or severe sensory impairments. Randomization will be stratified by age (< 12 vs ≥ 12 months), sex, and ASD symptom severity. FIRRST consists of weekly telehealth sessions delivered by trained licensed health professionals over 24 weeks. Outcomes will be assessed at baseline, post-intervention (24 weeks), and follow-up (48 weeks). OUTCOMES: The primary outcome is change in ADOS-2 Calibrated Severity Scores from baseline to post-intervention. Secondary outcomes include developmental level (Griffiths-III), caregiver-child interaction (MONSI-CC), parental well-being (PSI-4), and neurophysiological measures derived from high-density electroencephalography. Safety outcomes include monitoring and descriptive reporting of adverse events. A cost-effectiveness analysis will be conducted from the healthcare system perspective. TRIAL REGISTRATION: ClinicalTrials.gov NCT06817746 . Registered on November 2024.
引用
- Colombi C, Calderoni S, Chericoni N, et al. Fostering Infant Responsivity and Reciprocity - Support to Thrive (FIRRST): a multisite randomized control trial of a pre-emptive telehealth intervention for infants with early signs of Autism Spectrum Disorders in Italy. Trials. 2026. PMID: 42001120. doi:10.1186/s13063-026-09694-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。